U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

SILYBUM MARIANUM WHOLE

MORE DETAILS

JLK089424F

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT00412763: Phase 4 Interventional Completed Hepatitis
(2003)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT00412763
First approved in 2023
Source:
M006
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0dccdbc-56fd-4034-b479-f2a2ebde2234
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966